Introduction
Non-ST-elevation acute coronary syndrome (NSTEACS) is the most frequently encountered presentation of the acute coronary syndrome (ACS) in clinical practice, accounting for almost two-third of total hospital admissions for ACS in the USA and Europe [1] [2] [3] . A routine invasive strategy has been shown to be associated with a reduced risk of reinfarction, repeat hospitalization, and improved survival compared with a selective invasive or conservative approach, particularly in high-risk NSTEACS [4] [5] [6] such as those who are troponin positive. Early invasive coronary angiography (CA) helps to establish the presence and extent of coronary disease and appropriateness of revascularisation in the form of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery.
Specifically, meta-analyses reveal that an early invasive strategy does not reduce mortality compared with a delayed invasive strategy in all patients with NSTEACS, but there may be benefit in high-risk patients [9] [10] [11] [12] . Moreover, the timing of CA has changed significantly in the last decade due to expansion in services and changes in guideline recommendations around the cutoff for an invasive approach [13, 14] . There are limited data in contemporary practice and in national cohorts regarding temporal trends and changing characteristics of patients undergoing CA following a NSTEACS diagnosis at different time points.
The aims of this study were to investigate the temporal trends in timing to CA and to describe changes in the profile of patients undergoing early, intermediate and late CA following admission with NSTEACS over the past decade in the USA. Our second aim was to study these trends stratified according to age, ethnicity, sex and weekday versus weekend admission. Third, we investigated the independent predictors of early CA. Finally, we studied the association of in-hospital mortality, Major Adverse Cardiac and Cerebrovascular Events (MACCE), major bleeding with different time points of CA.
Patients and methods
The data for this study were derived from National Inpatient Sample (NIS), one of the largest publically available all-payer inpatient healthcare database sponsored by the Agency for Healthcare Research and Quality (AHRQ) as a part of Healthcare Cost and Utilization Project (HCUP) [15] . NIS collects discharge-level anonymised data encompassing more than seven million yearly hospital records. Ethical approval was not required for this study as NIS is publically available anonymised data.
We used International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) code of 4111 and 4107 to identify patients admitted with a primary diagnosis of NSTEACS from 2004 to 2014. Data were restricted to urgent or emergency diagnoses thereby excluding elective admissions, as they do not represent a true diagnosis of NSTEACS. CA was defined as ICD-9-CM procedure codes 8853, 8854, 8855, 8856 3722 and 3723, with or without PCI (ICD-9-CM procedure codes 0066, 3601, 3602, 3605, 3606 and 3607. Time to CA was categorized into early (day 0, 1), intermediate (day 2) and late (day ≥ 3). Patients who did not undergo CA comprise the conservative group.
We also collected information on patient demographics, including age, sex, race, median household income by zip code, primary expected payer, weekend admission and comorbidities using Elixhasuer comorbidities, as defined by AHRQ. The length of stay and total cost of hospitalization for each admission were recorded. The cost of hospitalization was calculated using cost-to-conversion ratio to convert the reported charges into the actual cost for the payer. In addition, hospital characteristics such as region, location, teaching status and bed size were also included. Finally, information around cardiovascular risk factors and other important relevant diagnoses such as the history of smoking, hyperlipidaemia, coronary artery disease (CAD), family history of ischaemic heart disease, previous myocardial infarction or CABG, and dementia were also extracted using ICD-9-CM codes provided in Supplementary Table 1 (Supplemental digital content 1, http://links.lww.com/MCA/A221). The ICD-9-CM coded used for calculating Charlson Comorbidity Index (CCI) are given in Supplementary Table 2 (Supplemental digital content 1, http://links.lww.com/MCA/A221).
The in-hospital mortality is collected in NIS database as DIED variable. Whereas, other in-hospital outcomes including major bleeding, acute ischaemic stroke, adverse cardiac complications, and MACCE; a composite of acute ischaemic stroke, in-hospital mortality and adverse cardiac complications were obtained using ICD-9-CM codes provided in Supplementary Table 3 (Supplemental digital content 1, http://links.lww.com/MCA/A221).
We compared the differences in the baseline, hospital characteristics, and crude outcomes of interest across all the four categories using descriptive statistics. Continuous variables were reported as the median and interquartile range to account for skewness of the data whereas categorical variables were presented as a number and percentage. All the analyses were undertaken using survey estimation command as recommended by AHRQ to account for complex survey design of NIS database. The updated AHRQ trend weights for years 2004-2011 (TRENDWT) and existing discharge weights for years 2012-2014 (DISCHWT) were used to produce national discharge-level estimates for trends analysis. Multivariable analyses were undertaken to investigate the independent predictors of early CA (day 0, 1) compared late (day ≥ 3) and association of time to CA category with aforementioned clinical outcomes. The following covariates were adjusted for in all analyses: age, sex, elective admission, weekend admission, primary expected payer, median household income, dyslipidaemia, smoking status, previous acute myocardial infarction (AMI), previous CABG, history of ischaemic heart disease, previous PCI, previous cerebrovascular accident, family history of CAD, use of assist device or intra-aortic balloon pump (IABP), shock during hospitalization, dementia, bed size of hospital, region of hospital, location/teaching status of hospital and 29 AHRQ comorbidities. All odds ratios (ORs) are adjusted for the aforementioned covariates and presented with the corresponding 95% confidence intervals (CIs). This methodology has previously been used for analysing data from HCUP [16] [17] [18] . STATA/MP, version 14 (StataCorp., College Station, Texas, USA) was used to perform all statistical analysis.
Results
We identified 4 380 827 records with a diagnosis of NSTEACS between 2004 and 2014, of which 1 862 123 (42.5%) were managed medically and 2 518 704 (57.5%) received CA. After excluding the records with missing information on time to CA (12%), the patients that received CA, 1 574 342 (62.5%), 302 668 (12.0%), 340 054 (13.5%) were categorized into early (day 0, 1), intermediate (day 2) and late (day ≥ 3) CA groups, respectively (Fig. 1) . Temporal trends in time to CA stratified according to the three groups is depicted in Fig. 2 . Specifically, the proportion undergoing early CA increased from 65.6 to 72.6% with a corresponding reduction in late CA from 19.6 to 13.5%. There significant differences in the profile of the patient undergoing CA at different time points. Patients receiving early CA were younger (median age: 64 vs. 70 years), more likely to be male (63.7 vs. 55.3%) and of Caucasian ethnic background (68.7 vs. 64.7%) compared with late CA group. Conversely, patient in the late CA group were more likely to be women, had higher proportions of coexisting comorbidities, and were more likely to be admitted on weekend days ( Table 1 ). The prevalence of risk factors for CAD including smoking, dyslipidemia, previous AMI, hypertension, and peripheral vascular disease has increased in both early and intermediate groups, but with a greater proportional increase observed in the early CA group (Table 2) . In contrast, patients undergoing late CA had a greater proportional increase in the noncardiac comorbidities throughout the study period.
There were significant disparities in the secular trends of CA in patients stratified according to sex, comorbidity burden, admission day, age and ethnicity. Temporal trends in the time to CA stratified according to sex reveal that early CA was comparatively higher in men (68.6-74.2%) during the study period, although there was a greater proportional increase in the use of early CA from 60.9 to 70.0% in women (Fig. 3 ). There were significant disparities in the time to CA use in patients with different comorbidity burden as defined by CCI (Fig. 4) . During the 11-year study period, the use of early CA increased from 75.0 to 82.1% in patients with no comorbidity (CCI = 0) compared with 47.2-58.3% in the CCI ≥ 3 category. For weekend admissions (Fig. 5 ), though (Fig. 6) . Similarly, overall, higher proportions of African American received late CA compared with early CA (12.7 vs. 8.9%) and this trend remained unchanged over the study period (Fig. 7) . Finally, patients with private insurance were more likely to have early CA (33.5%) than late CA (16.7%), whereas patients on medicare were more likely to have late CA (66.4%) than early CA (49.5%). More than half of all patients treated conservatively (54.2%) were on Medicare, whereas only 30.8% had private insurance (Table 1) .
We also studied independent clinical and institutional predictors of early CA as shown in Table 3 Crude outcomes stratified according to the three different time to CA are shown in Fig. 8 . In-hospital mortality in the early, intermediate and late were 1.8, 1.5 and 2.3% (P < 0.0001) respectively. Lower rates for crude MACCE and bleeding was observed in the early and intermediate category compared with late CA category as depicted in Fig. 8 . Multivariate analysis revealed that early CA was associated with reduced in-hospital mortality (OR = 0.39, 95% CI: 0.37-0.41), in-hospital stroke (OR = 0.86, 95% CI: 0.80-0.92) and MACCE (OR = 0.80, 95% CI: 0.77-0.83); however, the lowest risk was observed in intermediate category (Table 4) .
Discussion
In this large, contemporary cohort of patients admitted with a diagnosis of NSTEACS in the USA, there are several important observations. First, there is an increasing trend in use of early CA compared with intermediate and late CA over an 11-year period. Second, we observed significant changes in clinical characteristics and baseline risk profile of patients treated with early invasive CA compared with intermediate and late CA, so that use of early CA remains attenuated in elderly, complex and multimorbid patients despite an overall increase in adoption of early CA in NSTEACS. Third, there are significant disparities in use of early CA across different groups of patients particularly women and African Americans, who were less likely to receive early CA compared with men and caucasians. Fourth, the presence of noncardiac comorbidities such as liver disease, peripheral vascular disease, chronic renal failure, dementia and history of alcohol disease was inversely associated with receipt of an early CA. Finally, use of CA on day 2 from admission appears to be safe and feasible in the majority of the patients admitted following NSTEACS.
We demonstrate that women, African American and those without private insurance were less likely to undergo early CA. Women admitted with NSTEACS are older, burdened with more comorbidities and known to have higher risk of periprocedural bleeding when compared with men [19] . However, women have higher risk of ischaemic complications following NSTEACS admission such as reinfraction and repeat admission and therefore are more likely to benefit from an early invasive approach [20] [21] [22] . This is in keeping with the current AHA/ACC NSTEACS guidelines recommending an early invasive approach be adopted particularly in those with high-risk features to improve outcomes [14] . Lower utilization of invasive cardiac procedures has been reported in patients without private health insurance [23] . Consistent with literature, patients with private insurance were more likely to have early CA (33.5%) than late CA (16.7%), whereas patients on medicare were more likely to have late CA (66.4%) than early CA (49.5%). More than half of all patients treated conservatively (54.2%) were on Medicare, whereas only 30.8% had private insurance. Socioeconomic status, varying practices amongst treating physician and hospitals, lack of access to appropriate healthcare resources, and regional factors may be responsible for these biases in management in different patient groups when partitioned into payer categories [24] [25] [26] [27] [28] . Our study shows that there remain significant disparities in early aggressive treatment of these undertreated subgroup of patients and the need for development of uniform pathways to improve the outcomes in this underserved population.
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setting have mainly studied the association of clinical outcomes with a weekend admission [29] . In our large contemporary analysis, we illustrate that almost 30% of the patient admitted on weekend receive CA after 2 days compared with only 8.6% on a weekday. This trend has remained stable over the past decade.
In our study, it appears that there exists a treatment paradox where younger and less comorbid patients selectively receive early CA in contrast to older, multimorbid patients who may have more to gain from early CA and remain less likely to receive it. The presence of noncardiac comorbidities such as liver disease, chronic kidney disease, previous cerebrovascular accident, dementia, and peripheral vascular disease were strong negative predictors of early CA. Current guidelines recommend the use of early invasive strategy in patients presenting with high-risk features including ischaemic ECG changes, elevated troponin levels, new congestive heart failure symptoms, left ventricular dysfunction, or haemodynamic instability [13, 14] . Presence of cardiogenic shock or use of IABP, cardiovascular risk factors such as smoking, dyslipidaemia were strongly associated with early use of CA in our study.
Finally, we report an overall decreasing trend in in-hospital mortality, MACCE and in-hospital stroke in patients managed invasively compared with a conservative approach. Patients in the intermediate category receiving CA on day 2 appear to have lowest in-hospital mortality and MACCE, both in the unadjusted and adjusted analysis. Although it is widely believed that invasive strategy improves outcomes by reducing ischaemic complications following NSTEACS, the studies have shown inconsistent results regarding the timing of CA [9, 10, 30, 31] . It is important to note that majority of these studies are conducted in the pre-P2Y12 inhibitor era with far less aggressive pharmacotherapy compared with current practices. The main benefit of early invasive approach in NSTEACS in driven by the reduction in ischaemic complications such as reinfarction and future events [32] [33] [34] [35] . It is plausible that with newer potent antiplatelet and anticoagulant use, risk of ischaemic complications has reduced and an early invasive strategy can be deferred safely. Lindholm et al. [36] used data from SWEADHEART registry to study the optimal timing of invasive strategy in non-ST-elevation myocardial infarction patients demonstrating a 16% relative risk reduction (hazard ratio = 0.86, 95% CI: 0.77-0.97) in patients undergoing invasive treatment on day 2 or day 3, whereas no difference in death or myocardial infarction was found on day 1. National guidelines advocate a risk based approach in offering early invasive approach using validated risk scores such as Global Registry of Acute Coronary Events (GRACE) ACS score [13, 14] . It is important to mention that NIS data does not capture information around haemodynamic status, ECG findings, cardiac biomarker, severity of coronary disease and GRACE ACS score, therefore a true casual inference between optimal timing of CA and in-hospital outcomes cannot be inferred from this study.
These findings must be interpreted in the context of certain limitations. First, the time from admission to CA is calculated from admission to procedure day which may be confounded by interhospital transfers and unavailability of onsite CA facilities. The NIS does not collect information around the haemodynamic status, ECG changes and biomarker positivity, hence risk stratification scores such as the GRACE score cannot be calculated or adjusted. This may be particularly relevant in the early invasive group, where high-risk features such as dynamic ECG changes, biomarker positivity, on-going symptoms or adverse haemodynamic profiles may be over-represented in the early invasive group, and we are unable to adjust for these features. Consequently, this may have confounded the influence of earlier angiography on mortality in these patients. Previous work has suggested that the benefit of an early invasive approach was seen predominantly in those patients AMI, acute myocardial infarction; CABG, coronary artery bypass graft; CAD, coronary artery disease; CVA, cerebrovascular accident; IABP, intra-aortic balloon pump; IHD, ischaemic heart disease; IQR, interquartile range; PCI, percutaneous coronary intervention; RA, rheumatoid arthritis. Table 2 (continued) Valvular heart disease 0 with a high GRACE ACS score (GRACE > 140) [37] , hence we are unable to further study timing of CA as well as clinical outcomes stratified by the GRACE score.
Furthermore, the NIS does not capture the severity of CAD or antiplatelet therapy that are important determinants of clinical outcomes. Finally, it is important to note that NIS is an administrative database which is subject to coding errors in both diagnosis and procedure code.
Conclusion
In this large contemporary national analysis of patients admitted with NSTEACS in the USA, we observed an increasing trend in early CA associated with significant changes in baseline characteristics and risk profile of these patients compared with those receiving late CA. Although younger, healthier patients are more likely to receive early CA there remains important sex, ethnic, admission day and payment status inequalities in receipt of early CA. Women, African American, weekend admission and lack of private insurance were less likely to receive early CA. Future efforts should be focused around implementing a uniform risk guided approach in clinical practice and development of pathways to improve access to invasive CA in high-risk NSTEACS patients. Crude outcomes stratified according to time to coronary angiography. MACCE, Major Adverse Cardiac and Cerebrovascular Events. Trends in time to coronary angiography Rashid et al. 169
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